The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Incidence and precursors of hypertension in young adults: The Framingham offspring study
Abstract
The occurrence of hypertension and its precursors is examined in the Framingham Offspring Study of 2,027 men and 2,267 women ages 20-49 years followed for 8 years. The age-specific prevalence of hypertension was similar at both the first (1971-1975) and the second (1979-1983) examination for both men and women. Prevalence rates were higher among men than among women, and there was a higher rate of hypertension treatment at the second exam, particularly among women, 75% of whom reported being treated for hypertension. The incidence of hypertension in participants free from hypertension at the first examination increased threefold from the second to the fifth age decades in men and eight-fold in women. Under age 40, men were twice as likely as women to develop hypertension, but after age 40, 8-year incidence rates were similar in men (14.2%) and women (12.9%). Adiposity, relative weight, heart rate, alcohol intake, hematocrit, blood sugar, serum protein, triglyceride, and phosphorous were all related to hypertension occurrence in one or both sexes, controlling for age. In multivariate analysis, adiposity (P less than 0.01), heart rate (P less than 0.01), and triglyceride (P less than 0.05) were all significant independent predictors of hypertension in men. In women, adiposity (P less than 0.001), heart rate (P less than 0.01), hematocrit (P less than 0.05), and alcohol consumption (P less than 0.05) were independent contributors. When controlling for blood pressure measured at the first examination, the best single predictor of hypertension incidence, the multivariate assessment changed very little. Adiposity stands out as a major controllable contributor to hypertension. Changes in body fat over 8 years were related to changes in both systolic and diastolic blood pressure. Markedly obese women in their fourth decade were seven times more likely to develop hypertension than were lean women of the same age. Weight control deserves a high priority in efforts to prevent hypertension in the general population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epidemiology studies indicate that 65–75% of primary (essential) hypertension is due to overweight or obesity7.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [7]
In the citing paper
“Excess adiposity, especially when localized in visceral regions and around the kidneys, accounts for 65–75% of the risk of primary hypertension6,7.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [7]
In the citing paper
“Excess weight gain, especially when associated with increased visceral adiposity, is a major cause of hypertension, accounting for 65–75% of the risk for human primary (essential) hypertension.”
From Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms (2015) · cites this paper as [7]
In the citing paper
“Risk estimates from the Framingham Heart Study, for example, suggest that 78 percent of primary (essential) hypertension in men and 65% in women can be ascribed to excess weight gain7.”
From Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms (2015) · cites this paper as [7]
Citations
Cites
Relation of Body Fat Distribution to Metabolic Complications of Obesity*
KISSEBAH, A. H., VYDELINGUM, N., MURRAY, R., EVANS, D. J., KALKHOFF, R. K., & ADAMS, P. W. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-2-254 · Cited by 1,909
Effects Morbidity of Treatment on in Hypertension
Veterans Administration Cooperative Study Group on Antihypertensive Agents (1970) · JAMA · doi:10.1001/jama.213.7.1143 · Cited by 1,740
Estimation of the Probability of an Event as a Function of Several Independent Variables
Walker, S. H., & Duncan, D. B. (1967) · Biometrika · doi:10.1093/biomet/54.1-2.167 · Cited by 1,683
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
Self-citationVeterans Administration Cooperative Study Group on Antihypertensive Agents (1967) · JAMA · doi:10.1001/jama.202.11.1028 · Cited by 1,316
TOXIC-SHOCK SYNDROME NOT ASSOCIATED WITH MENSTRUATION
Reingold, A. L., Shands, K. N., Dan, B. B., & Broome, C. V. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92552-1 · Cited by 1,164
Lipid Research Clinics Program
Renfrew, R. A. (1984) · JAMA · doi:10.1001/jama.1984.03350180015009 · Cited by 829
Reisin, E., Abel, R., Modan, M., Silverberg, D. S., Eliahou, H. E., & Modan, B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197801052980101 · Cited by 759
Physical Fitness and Incidence of Hypertension in Healthy Normotensive Men and Women
Blair, S. N. (1984) · JAMA · doi:10.1001/jama.1984.03350040017014 · Cited by 706
Research works printed but not linked: 4
- 1980, Lancet, 1261
- Frisancho, 1982, Advanced maturation associated with centripital fat pattern, Human Biol., 54, 717
- 1979, JAMA, 242, 2562, 10.1001/jama.242.23.2562 · DOI · Paper page
- Kannel, 1979, An investigation of coronary heart disease in families: The Framingham Offspring Study, Amer. J. Epidemiol., 110, 281, 10.1093/oxfordjournals.aje.a112813 · DOI
Cited by
Sorted by citations
Items 401–500 of 785
Zhou, J., Ma, H., Shao, J., Wei, Y., Zhang, X., Zhang, Y., & Li, D. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011434 · Cited by 17
Yao, F., Liu, W., Zhao, R., Li, G., Huang, X., & Chen, Y. (2020) · BMC Public Health · doi:10.1186/s12889-020-8428-z · Cited by 16
Yun, M., Zhang, T., Li, S., Wang, X., Fan, L., Yan, Y., Bazzano, L., He, J., & Chen, W. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00810-9 · Cited by 16
Lausten‐Thomsen, U., Bille, D. S., Thagaard, I. N., Folskov, L., Larsen, T., & Holm, J. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-1949-z · Cited by 16
Total and Abdominal Adiposity and Hypertension in Indigenous Women in Midwest Brazil
Almeida, J. B., Kian, K. O., Lima, R. C., & de Souza, M. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155528 · Cited by 16
Ebadinejad, A., Shahshahani, M., Hosseinpanah, F., Ghazy, F., Khalaj, A., Mahdavi, M., Valizadeh, M., & Barzin, M. (2023) · Hypertension Research · doi:10.1038/s41440-023-01180-7 · Cited by 14
Home Blood Pressure Monitoring
Liu, J., Brettler, J. W., Ramirez, U. A., Walsh, S., Sangapalaarachchi, D. N., Narita, K., Byfield, R. L., Reynolds, K., & Shimbo, D. (2024) · American Journal of Hypertension · doi:10.1093/ajh/hpae151 · Cited by 23
Impaired dopamine D1 receptor-mediated vasorelaxation of mesenteric arteries in obese Zucker rats
Fu, J., Han, Y., Wang, H., Wang, Z., Liu, Y., Chen, X., Cai, Y., Guan, W., Yang, D., Asico, L. D., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-50 · Cited by 15
Therapeutic Considerations in the Treatment of Obesity Hypertension
Wofford, M. R., Davis, M. M., Harkins, K. G., King, D. S., Wyatt, S. B., & Jones, D. W. (2002) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.00502.x · Cited by 15
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Oparil, S., & Pimenta (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s5702 · Cited by 15
Blood Pressure Lowering Effects of Rimonabant in Obesity‐related Hypertension
Grassi, G. M., Quarti‐Trevano, F., Seravalle, G., Arenare, F., Brambilla, G., & Mancia, G. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01688.x · Cited by 15
Genelhu, V. A., Celoria, B. M. J., Pimentel, M. M. G., Duarte, S. F. P., Cabello, P. H., & Francischetti, E. A. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.7 · Cited by 15
Angeli, F., Reboldi, G., & Verdecchia, P. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283625055 · Cited by 15
Epidemiology of Risk Factor Clustering in Elevated Blood Pressure
Kannel, W. B., Wilson, P. W. F., Silbershatz, H., & D’Agostino, R. B. (1998) · Medical science symposia series · doi:10.1007/978-94-011-5022-4_37 · Cited by 14
Self-citationSchillaci, G., & Pirro, M. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.088146 · Cited by 15
Su, Y., Sun, J.-Y., Su, Z., & Sun, W. (2024) · Current Cardiology Reviews · doi:10.2174/011573403x290574240322041356 · Cited by 17
Zhou, L., Li, Y., Guo, M., Wu, Y., & Zhao, L. (2016) · Hypertension Research · doi:10.1038/hr.2016.80 · Cited by 14
Jemtel, T. H. L., Richardson, W., Samson, R., Jaiswal, A., & Oparil, S. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0713-6 · Cited by 14
Figliuzzi, I., Presta, V., Miceli, F., Citoni, B., Coluccia, R., Ceccarini, G., Salvetti, G., Santini, F., Musumeci, B., Ferrucci, A., et al. (2018) · Journal of Human Hypertension · doi:10.1038/s41371-018-0132-4 · Cited by 14
Garcia, M. L., Milanez, M. I. O., Nishi, E. E., Sato, A. Y. S., de Carvalho, P. M., Nogueira, F. N., Campos, R. R., Oyama, L. M., & Bergamaschi, C. T. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119841 · Cited by 14
Li, J., Zhu, J. Q., Tan, Z., Yu, Y., Luo, L., Zhou, W., Zhu, L., Wang, T., Cao, T., Liu, L., et al. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00617-5 · Cited by 14
Soluble (Pro)Renin Receptor in Hypertension
Yang, T. (2022) · The Nephron journals/Nephron journals · doi:10.1159/000525635 · Cited by 15
Non-drug therapy in prevention and control of hypertension.
Sainani, G. S. (2003) · PubMed · Cited by 14
Association of metabolic risk factors with uncontrolled hypertension
Cortez‐Dias, N., Martins, S. R., Belo, A., & Fiúza, M. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32836342f7 · Cited by 14
Therapeutic Lifestyle Changes for Cardiovascular Disease
Wexler, R., Pleister, A. P., Raman, S. V., & Borchers, J. R. (2012) · The Physician and Sportsmedicine · doi:10.3810/psm.2012.02.1957 · Cited by 14
High Heart Rate as Predictor of Essential Hypertension:
Tjugen, T. B., Flaa, A., & Kjeldsen, S. E. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.05.008 · Cited by 14
Bouchi, R., Ohara, N., Asakawa, M., Nakano, Y., Takeuchi, T., Murakami, M., Sasahara, Y., Numasawa, M., Minami, I., Izumiyama, H., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0335-3 · Cited by 14
Lifecourse Drinking Patterns, Hypertension, and Heart Problems Among U.S. Adults
Lui, C. K., Kerr, W. C., Li, L., Mulia, N., Ye, Y., Williams, E., Greenfield, T. K., & Lown, E. A. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.10.018 · Cited by 14
Chadid, S., Kreger, B. E., Singer, M. R., Bradlee, M. L., & Moore, L. L. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0519-5 · Cited by 14
SAH gene variants are associated with obesity-related hypertension in Caucasians: the PEGASE Study
Telgmann, R., Brand, E., Nicaud, V., Hagedorn, C., Beining, K., Schönfelder, J., Brink-Spalink, V., Schmidt‐Petersen, K., Matanis, T., Vischer, P., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280144779 · Cited by 14
Costa, M. B., Ezequiel, D. G. A., Lovisi, J. C. M., Oliveira, M. M. E., & de Paula, R. B. (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00339.x · Cited by 14
The association between obesity and hypertension in blacks
Kumanyika, S. (2009) · Clinical Cardiology · doi:10.1002/clc.4960121314 · Cited by 14
Cardiovascular Risk in Pediatrics: A Dynamic Process during the First 1000 Days of Life
Calcaterra, V., Mannarino, S., Garella, V., Rossi, V., Biganzoli, E. M., & Zuccotti, G. (2023) · Pediatric Reports · doi:10.3390/pediatric15040058 · Cited by 13
Recent advances in targeting obesity, with a focus on TGF-β signaling and vagus nerve innervation
John, S., Bhowmick, K., PARK, A. W., Huang, H., Yang, X., & Mishra, L. (2025) · Bioelectronic Medicine · doi:10.1186/s42234-025-00172-x · Cited by 15
Heart rate variability in normotensive subjects with family history of hypertension.
Muralikrishnan, K., Kabali, B., & Rao, B. V. (2011) · PubMed · Cited by 13
Are Women with Normal-Weight Obesity at Higher Risk for Cardiometabolic Disorders?
Ashtary‐Larky, D., Niknam, S., Alipour, M., Bagheri, R., Asbaghi, O., Mohammadian, M., Jaime, S. J., Baker, J. S., Wong, A., Suzuki, K., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020341 · Cited by 13
Blood pressure response to moderate physical activity is increased in obesity.
Burger, J. P. W., Serné, E. H., Nolte, F., & Smulders, Y. M. (2009) · PubMed · Cited by 13
Simonds, S. E., Pryor, J. T., Koegler, F. H., Buch-Rasmussen, A. S., Kelly, L. E., Grove, K. L., & Cowley, M. A. (2019) · Diabetes · doi:10.2337/db18-1149 · Cited by 13
Diabetes and Hypertension: A Review
Sowers, J. R., & Khoury, S. (1991) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(21)00343-2 · Cited by 13
Abdominal Obesity Is Characterized by Higher Pulse Pressure: Possible Role of Free Triiodothyronine
Pergola, G. D., Nardecchia, A., Ammirati, A., Caccavo, D., Bavaro, S., & Silvestris, F. (2012) · Journal of Obesity · doi:10.1155/2012/656303 · Cited by 13
Metabolic Risk Factors and Markers of Cardiovascular and Renal Damage in Overweight Subjects
Bigazzi, R., Bianchi, S., Batini, V., GUZZO, D., & Campese, V. M. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.10.002 · Cited by 13
Widgren, B. R., Urbanavičius, V., Attvall, S., & Persson, B. (1994) · Metabolism · doi:10.1016/0026-0495(94)90271-2 · Cited by 13
Ohya, Y., Maruhashi, S., & Ouchi, T. (1998) · Macromolecular Chemistry and Physics · doi:10.1002/(sici)1521-3935(19980901)199:9 · Cited by 58
Obesity and Atrial Fibrillation: From Mechanisms to Treatment
Dziano, J. K., Ariyaratnam, J., Middeldorp, M. E., Sanders, P., & Elliott, A. D. (2025) · Heart Lung and Circulation · doi:10.1016/j.hlc.2025.08.003 · Cited by 14
Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity
Gudzune, K. A., Apovian, C. M., Aroda, V. R., Aronne, L. J., Balapattabi, K., Bennett, A. K., ChallaSivaKanaka, S., ElSayed, N. A., Fitch, A., Fitzpatrick, S. L., et al. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doci25-0008 · Cited by 15
Silva, E. A., Flexa, F., & Zanella, M. T. (2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007001400003 · Cited by 11
Ajabnoor, G., Bahijri, S., Alamoudi, A. A., Al-Raddadi, R. M., Al-Ahmadi, J., Jambi, H., Borai, A., & Toumilehto, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246568 · Cited by 15
Risk factors for coronary heart disease: Synthesis of a new hypothesis through adaptation
Singh, R. B., & Mori, H. (1992) · Medical Hypotheses · doi:10.1016/0306-9877(92)90058-k · Cited by 12
Shank, L. M., Schvey, N. A., Ekundayo, K., Schreiber-Gregory, D. N., Bates, D., Maurer, D., Spieker, E. A., Stephens, M. B., Tanofsky‐Kraff, M., & Sbrocco, T. (2018) · Body Image · doi:10.1016/j.bodyim.2018.11.003 · Cited by 12
Osella, A. R., Dı́az, M. D. P., Cozzolongo, R., Bonfiglio, C., Franco, I., Abbrescia, D. I., Bianco, A., Buongiorno, G., Elba, S., Petruzzi, J., et al. (2014) · Revista de la Facultad de Ciencias Médicas de Córdoba · doi:10.31053/1853.0605.v71.n3.10135 · Cited by 12
Steroid sulfatase inhibitor alters blood pressure and steroid profiles in hypertensive rats
Valigora, S. D., Li, P., Dunphy, G., Turner, M. E., & Ely, D. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00062-5 · Cited by 12
Sanjuliani, A. F., Ea, F., de Abreu, G., & Ueleres Braga, J. (2005) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 12
Rao, J., Yan, Y., Cheng, H., Hou, D., Zhao, X., Shan, X., & Mi, J. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.10.007 · Cited by 11
Healthy weight – healthy blood pressure
Chockalingam, A. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70380-9 · Cited by 11
Goh, B. H., Cheng, H. S., Alexandra, P. T. A. P. A., Ting, K., Palanisamy, U. D., & Tan, J. B. L. (2023) · Nutrients · doi:10.3390/nu15122696 · Cited by 11
Obesity and Overweight in Ethnic Minorities of the Detroit Metropolitan Area of Michigan
Jamil, H. J., Rajan, A. K., Grzybowski, M., Fakhouri, M., & Arnetz, B. B. (2013) · Journal of Community Health · doi:10.1007/s10900-013-9760-3 · Cited by 11
Physiology and Pathophysiology of Hypertension
Hall, J. E., Granger, J. P., & Hall, M. E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00039-2 · Cited by 11
Rodríguez, R., Moreno, M., Lee, A. Y., Godoy-Lugo, J. A., Nakano, D., Nishiyama, A., Parkes, D. G., Awayda, M. S., & Ortiz, R. M. (2018) · Hypertension Research · doi:10.1038/s41440-018-0070-0 · Cited by 11
Li, Y., Zhang, Y., Zhang, M., Yang, W., Ji, B., Pan, H., & Ban, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-44299-9 · Cited by 11
Modjadji, P., Bokaba, M., Mokwena, K. E., Mudau, T. S., Monyeki, K. D., & Mphekgwana, P. M. (2022) · Applied Sciences · doi:10.3390/app12031685 · Cited by 11
Nakanishi, N., Nakamura, K., SUZUKI, K. S., Matsuo, Y., & Tatara, K. (2000) · Industrial Health · doi:10.2486/indhealth.38.233 · Cited by 11
Comstock, B. A., Thomas, G. A., Dunn‐Lewis, C., Volek, J. S., Szivak, T. K., Hooper, D. R., Kupchak, B. R., Flanagan, S. D., Denegar, C. R., & Kraemer, W. J. (2013) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e31828f8202 · Cited by 11
Nakanishi, N., Suzuki, K., & Tatara, K. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000065929.57001.04 · Cited by 11
Metabolic Consequences of Obesity
Hu, F. B. (2008) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195312911.003.0008 · Cited by 11
Primary and Secondary Hypertension
Blumenfeld, J. D., Liu, F., & Laragh, J. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10046-6 · Cited by 11
Yadav, D., Kang, D. R., Koh, S. B., Kim, J., & Ahn, S. V. (2016) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.6.1454 · Cited by 11
Okabayashi, K., Kasahara, E., Uchiyama, H., Yokota, K., Togashi, Y., Kono, C., Yamada, Y., Amano, H., Yamaguchi, T., Kawamoto, T., et al. (2007) · Journal of Occupational Health · doi:10.1539/joh.49.117 · Cited by 11
Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity
C, K. A. C. M. V. R. L. J. K. A. G. A. A. A. B. B. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005729 · Cited by 18
Chronic Kidney Disease in Patients With Heart Failure With a Preserved Ejection Fraction
Packer, M., Testani, J. M., Butler, J., Zannad, F. M., Lam, C. S. P., Vaduganathan, M., Fang, J. C., & Borlaug, B. A. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.086 · Cited by 12
Luzes, R., Crisóstomo, T., Silva, P. A., Iack, R., de Abreu, V. G., Francischetti, E. A., & Vieyra, A. R. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166012 · Cited by 8
An Introduction to Cardiovascular Disease
Davidson, D. M. (1994) · Springer eBooks · doi:10.1007/978-1-4899-2572-5_1 · Cited by 10
Intrarenal Ghrelin Receptor Antagonism Prevents High-Fat Diet-Induced Hypertension in Male Rats
Kemp, B. A., Howell, N. L., Gildea, J. J., & Padia, S. H. (2014) · Endocrinology · doi:10.1210/en.2013-2177 · Cited by 10
Dominguez, L. J., Sayón-Orea, C., Gea, A., Toledo, E., Barbagallo, M., & Martínez‐González, M. Á. (2021) · Nutrients · doi:10.3390/nu13103309 · Cited by 11
CYP450, COX-2 and Obesity Related Renal Damage
Imig, J. D., Zhao, X., Dey, A., & Shaw, M. (2005) · Toxicology Mechanisms and Methods · doi:10.1080/15376520590918856 · Cited by 10
Morrison, R. G., Mills, C. N., Moran, A. L., Walton, C. E., Sadek, M. H., Mangiarua, E. I., Wehner, P. S., & McCumbee, W. D. (2007) · Clinical and Experimental Hypertension · doi:10.1080/10641960701578360 · Cited by 10
Horton, W. B., Jahn, L. A., Hartline, L. M., Aylor, K. W., Patrie, J. T., & Barrett, E. J. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211011009 · Cited by 10
Gillum, R. F. (1991) · PubMed · Cited by 10
What can we do about the “epidemic” of obesity
Hall, J. E., & Jones, D. W. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02960-6 · Cited by 10
Berillo, O., Comeau, K., Caillon, A., Leclerc, S., Shokoples, B. G., Mahmoud, A., Andelfinger, G., Paradis, P., & Schiffrin, E. L. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003725 · Cited by 9
Obesity and Chronic Kidney Disease: The Dual Epidemic in Cardiovascular Health
Grant, C. H., & Bell, S. (2025) · European Cardiology Review · doi:10.15420/ecr.2025.33 · Cited by 11
Zhang, X., Li, G., Shi, C., Tian, Y., Zhang, L., Zhang, H., & Sun, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-34969-0 · Cited by 10
Lee, K., Na, J. O., Choi, C. U., Lim, H. E., Kim, J. W., Kim, E. J., Rha, S., Seo, H. S., Oh, D. J., & Park, C. G. (2015) · Clinical Hypertension · doi:10.1186/s40885-016-0043-z · Cited by 9
Diabetic Nephropathy: Scope of the Problem
Chen, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0793-9_2 · Cited by 9
Isomura, M., Wang, T., Yamasaki, M., Hasan, M. Z., Shiwaku, K., & Nabika, T. (2015) · Disease Markers · doi:10.1155/2015/825435 · Cited by 9
Yako, Y. Y., Fanampe, B. L., Hassan, S. M., Erasmus, R. T., van der Merwe, L., & Matsha, T. E. (2011) · PubMed · Cited by 9
Reviving the use of aldosterone inhibitors in treating hypertension in obesity
Huby, A.-C., & de Chantemèle, E. J. B. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00133.2015 · Cited by 9
Baird, S. W., Jin, Z., Okajima, K., Russo, C. A., Schwartz, J. E., Elkind, M. S. V., Rundek, T., Homma, S., Sacco, R. L., & Tullio, M. R. D. (2017) · Journal of Human Hypertension · doi:10.1038/s41371-017-0021-2 · Cited by 9
Microalbuminuria and Proximal Tubule Remodeling in the Cardiometabolic Syndrome
Hayden, M. R., Chowdhury, N. A., Witte, L., & Sowers, J. R. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2006.05625.x · Cited by 9
Oparil, S., Abate, N. I., Chen, E., Creager, M. A., Galet, V. A., Jia, G., Julius, S., Lerman, A., Lyle, P. A., Pool, J. L., et al. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x280716 · Cited by 9
Are blood pressure levels increasing in Denmark?
Clausen, J. S. R., & Jensen, G. B. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00261.x · Cited by 9
Unmasking Hormonal Mechanisms of Hypertension in Obesity
Salle, S. P., Tsai, C., Newman, A. J., Chan, J. M., Milks, J., Adler, G. K., Ferrebus, A., Hanna, I., Mahrokhian, S., Pitt, B., et al. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101526 · Cited by 12
Obesity and Metabolic Syndrome Hypertension
Hall, M. E., Wang, Z., do Carmo, J. M., Kamimura, D., & Hall, J. E. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_42 · Cited by 8
Liao, J., Qiu, M., Li, J., Li, Y., & Han, Y. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14953 · Cited by 8
Reduction of leptin levels by four cardiac hormones: Implications for hypertension in obesity
Lane, M. L., & Vesely, D. L. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1173 · Cited by 8
Prevalence of hypertension among obese and non-obese patients with coronary artery disease.
Khan, S. B., Noor, L., Hafiz-Ur-Rehman, Hameedullah, Hafeezullah, M., Awan, Z. A., Din, S. U., & Shah, S. S. (2010) · PubMed · Cited by 8
Thapliyal, V., Singh, K., & Joshi, A. (2018) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.6.2.22 · Cited by 8
Francischetti, E. A., de Abreu, V. G., Figueiredo, L. F. D. S., Dezonne, R. S., & Coutinho, E. S. F. (2020) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00393-x · Cited by 8
Mokgwathi, M., & Mwita, J. C. (2020) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2019-062 · Cited by 7
Referrals to, and characteristics of patients attending a specialist hypertension clinic
Kennedy, C., Farnan, R., Stinson, J. C., Hall, M., Hemeryck, L., O’Connor, P., Hennessy, M., & Barry, M. G. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-021-00514-7 · Cited by 8
Cheng, L., Wang, L., Chen, B., Wang, C., Wang, M., Li, J., Gao, X., Zhang, Z., & Han, L. (2022) · Metabolomics · doi:10.1007/s11306-022-01942-3 · Cited by 8
Metadata
- Authors
- Garrison, R. J., Kannel, W. B., Stokes, J., & Castelli, W. P.
- Affiliations
- National Heart, Lung, and Blood Institute (US)
- Boston University (US)
- Corresponding author
- Garrison, Robert J.
- Venue
- Preventive Medicine
- Publisher
- Elsevier BV
- Published
- 1987-03
- Volume
- 16
- Issue
- 2
- Pages
- 235-251
- ISSN
- 0091-7435 (ISSN-L)
- OpenAlex
- W2013332206
- Cited by
- 789
- References
- 49
- Citations by year
- 2026: 18 · 2025: 30 · 2024: 31 · 2023: 28 · 2022: 19 · 2021: 35 · 2020: 30 · 2019: 16 · 2018: 32 · 2017: 24 · 2016: 38 · 2015: 29 · 2014: 37 · 2013: 33 · 2012: 38
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Preventive Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (N01-HV-92922)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- hypertension incidence, hypertension prevalence, young adults, adiposity, obesity, heart rate, triglycerides, alcohol consumption, hematocrit, sex differences, weight management, hypertension risk factors, Framingham Offspring Study
- MeSH terms
- Adult, Alcohol Drinking, Blood Pressure, Female, Humans, Hypertension, Lipids, Male, Middle Aged, Obesity, Risk, Smoking
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review